The history of Sildenafil presents a intricate picture for investors. While the initial release generated significant profits, the end of its intellectual property protection opened the door to off-brand versions, dramatically reducing revenue. This presents a unique risk for drug manufacturers depending on comparable blockbuster medications, sugge

The history of Viagra, and its creator copyright, presents a complex case study for investors. Initially a blockbuster drug, generating billions in income, its patent expiration created a wave of knock-off medications, significantly diminishing its position . While some businesses may attempt to capitalize on related treatments , the existing lands